MS

Mallanduru Srinivas Gowda Lohith

Active Director Director DIN 11339807
DIN 11339807 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mallanduru Srinivas Gowda Lohith

Data last updated:

Mallanduru Srinivas Gowda Lohith is a Director at Aventus Drugs Private Limited (since 2025). The company operates in Pharma.

DIN 11339807
Primary Designation Director
Industry Pharma
First Appointment 13 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aventus Drugs Private Limited U46497KA2025PTC209625
Director13 Oct 20252025Active

Board colleagues of Mallanduru Srinivas Gowda Lohith

NameDINCompanyDesignation
Thikkur Venkatesh Ashwitha11339808Aventus Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aventus Drugs Private Limited
Premium access

Shareholding and investment profile for Mallanduru Srinivas Gowda Lohith

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mallanduru Srinivas Gowda Lohith

Mallanduru Srinivas Gowda Lohith currently holds 1 directorship: Aventus Drugs Private Limited (Director, since 13 Oct 2025).

Mallanduru Srinivas Gowda Lohith was first appointed on 13 Oct 2025 as Director at Aventus Drugs Private Limited.

The current boards of Mallanduru Srinivas Gowda Lohith's companies include Thikkur Venkatesh Ashwitha (Aventus Drugs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available